Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder

March 5, 2018 updated by: David Mataix-Cols, Karolinska Institutet

Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder: A Feasibility Study

The purpose of this study is to evaluate the feasibility and acceptability of two different modalities of therapist-guided Internet-delivered behaviour therapy (IBT) for children and adolescents (7-17 years) with Tourette's Disorder (TD) or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD).

Study Overview

Detailed Description

The primary objective of this study is to evaluate the feasibility and acceptability of two different modalities of therapist-guided Internet-delivered behaviour therapy (IBT) for children and adolescents (7-17 years) with Tourette's Disorder (TD) or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD). The two modalities of IBT are habit reversal training (HRT) and exposure and response prevention (ERP). Secondary objectives are to evaluate whether IBT can decrease tic frequency and tic-related impairment, and, as both HRT and ERP have been proven efficacious in treating TD/PTD face-to-face, are any of the two treatments better suited to be delivered via the internet?

The design of the study is a randomized-controlled trial with 20 participants. Participants will be stratified by ADHD/ADD status.

The treatment duration is 10 weeks.

Feasibility and acceptability will be assumed if:

  • The two treatments can be successfully adapted to a therapist guided internet-delivered format (technical feasibility)
  • Patients/parents are willing to try the offered treatment modalities
  • Participants complete the active parts of the treatment
  • Referrers are open to the idea of internet-delivered treatment for TD or PTD
  • We can recruit sufficient numbers of patients for a fully powered efficacy trial

Regarding the secondary objective, the primary outcome is tic severity measured by the Yale Global Tic Severity Scale (YGTSS). Participants will be assessed directly after treatment (post), and at 3, 6 and 12 months after treatment. Assessments at post-treatment and 3 month follow up will be performed by assessors blinded to the treatment condition. After 3 months, we will naturalistically follow up patients up to 12 months after the end of treatment. Data collection will finish 12 months after treatment.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 113 30
        • BUP CPF

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Fulfill DSM-5 diagnostic criteria for Tourette's Disorder or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD).
  • >15 (TD) or >10 (PTD) on Yale Global Tic Severity Scale (Impairment not included).
  • Both child and parent are able to read and communicate in Swedish.
  • Regular access to a computer and the Internet.
  • Parent availability to support their child throughout the treatment.

Exclusion Criteria:

  • Acute psychiatric problems such as severe depression, suicidal risk, substance abuse or another psychiatric disorder that could interfere with treatment.
  • Lifetime history of global learning disability, pervasive developmental disorder, psychosis, bipolar disorder or organic brain disorder.
  • Severe tics causing immediate risk to the patients or others and requiring urgent medical attention.
  • Previous behavioural therapy (HRT or ERP), minimum 8 sessions with qualified therapist, within the last 12 months prior to assessment.
  • Simultaneous psychological treatment for tic disorder.
  • Initiation or adjustment of any psychotropic medication for tics within the last 6 weeks prior to assessment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: I-HRT
Internet-delivered habit reversal training
The I-HRT group will receive a 10-week therapist-guided, parent-assisted, Internet-delivered behavioural treatment. The treatment is based on existing literature on habit reversal training (i.e. Woods, D.W. (2008). Managing Tourette syndrome: A behavioral intervention for children and adults therapist guide. OUP, USA.) with added interactive features as videos and illustrations. In short, the participants practice to become more aware of their tics and inhibit them by performing competing responses (movements). The treatment is therapist guided: the participants have regular (up to 5 days a week) contact with a personally assigned therapist via written text in the platform and occasionally via the telephone. The children and parents have separate logins and access partly different content.
Other Names:
  • HRT, HR
Experimental: I-ERP
Internet-delivered exposure and response prevention
The I-ERP group receives a 10-week therapist-guided, parent-assisted, Internet-delivered behavioural treatment. The treatment is based on existing literature on exposure and response prevention (i.e. Verdellen, C. et al. (2011). Tics: Therapist manual & workbook for children. Boom, Amsterd.) with added interactive features as videos and illustrations. In short, the participants practice to suppress their tics for longer and longer times, at the same time as premonitory urges are intentionally provoked. The treatment is therapist-guided: the children and parents have regular (up to 5 days a week) contact with a personally assigned therapist via written text in the platform and occasionally via the telephone. The children and parents have separate logins and access partly different content.
Other Names:
  • ERP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Yale Global Tic Severity Scale (YGTSS)
Time Frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Change in tic severity (motor and/or vocal tics) from week 0 (pre treatment) to week 10 (post treatment), 3 months follow up (after post treatment), 6 months follow up and 12 months follow up.
Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up

Secondary Outcome Measures

Outcome Measure
Time Frame
Clinical Global Impression - Severity (CGI-S)
Time Frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Clinical Global Impression - Improvement (CGI-I)
Time Frame: Week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 10; 3 months follow up; 6 months follow up; 12 months follow up
Children's Global Assessment Scale (C-GAS)
Time Frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Parent Tic Questionnaire (PTQ)
Time Frame: Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Premonitory urge for Tics Scale (PUTS)
Time Frame: Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Gilles de la Tourette Syndrome Quality of Life Scale (GTS-QOL).
Time Frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Obsessive-Compulsive Inventory - Child version (OCI-CV).
Time Frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Children's Depression Inventory - Short version (CDI-S), with additional suicidality item
Time Frame: Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Mood and Feeling Questionnaire - Short version (MFQ)
Time Frame: Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Education, Work and Social Adjustment Scale - Child version (EWSAS-C)
Time Frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Education, Work and Social Adjustment Scale - Parent version (EWSAS-P)
Time Frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up
Treatment credibility scale
Time Frame: Week 3
Week 3
Treatment satisfaction scale
Time Frame: Week 10
Week 10
Safety Monitoring Uniform Report Form (SMURF)
Time Frame: Week 5; week 10
Week 5; week 10
Internet Intervention Patient Adherence Scale (iiPAS)
Time Frame: Week 5; week 10
Week 5; week 10
Parental strategy scale
Time Frame: Week 10
Week 10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David Mataix-Cols, Professor, Karolinska Institutet, department of clinical neuroscience

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2016

Primary Completion (Actual)

January 1, 2018

Study Completion (Actual)

January 1, 2018

Study Registration Dates

First Submitted

August 9, 2016

First Submitted That Met QC Criteria

August 11, 2016

First Posted (Estimate)

August 12, 2016

Study Record Updates

Last Update Posted (Actual)

March 6, 2018

Last Update Submitted That Met QC Criteria

March 5, 2018

Last Verified

March 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tourette's Disorder

Clinical Trials on Internet-delivered habit reversal training

3
Subscribe